63 related articles for article (PubMed ID: 37556413)
1. Incremental cost and cost-effectiveness of low-dose, high-frequency training in basic emergency obstetric and newborn care as compared to status quo: part of a cluster-randomized training intervention evaluation in Ghana.
Willcox M; Harrison H; Asiedu A; Nelson A; Gomez P; LeFevre A
Global Health; 2017 Dec; 13(1):88. PubMed ID: 29212509
[TBL] [Abstract][Full Text] [Related]
2. A Nighttime Telemedicine and Medication Delivery Service to Avert Pediatric Emergencies in Haiti: An Exploratory Cost-Effectiveness Analysis.
Flaherty KE; Klarman MB; Cajusma Y; Schon J; Exantus L; Beau de Rochars VM; Baril C; Becker TK; Nelson EJ
Am J Trop Med Hyg; 2022 Apr; 106(4):1063-1071. PubMed ID: 35189597
[TBL] [Abstract][Full Text] [Related]
3. Costs of seasonal influenza vaccine delivery in a pediatric demonstration project for children aged 6-23 months - Nakuru and Mombasa Counties, Kenya, 2019-2021.
Gharpure R; Akumu AO; Dawa J; Gobin S; Adhikari BB; Lafond KE; Fischer LS; Mirieri H; Mwazighe H; Tabu C; Jalang'o R; Kamau P; Silali C; Kalani R; Oginga P; Jewa I; Njenga V; Ebama MS; Bresee JS; Njenga MK; Osoro E; Meltzer MI; Emukule GO
Vaccine; 2023 Dec; ():. PubMed ID: 38154992
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of a multiplex lateral flow rapid diagnostic test for acute non-malarial febrile illness in rural Cambodia and Bangladesh.
Chew R; Painter C; Pan-Ngum W; Day NPJ; Lubell Y
Lancet Reg Health Southeast Asia; 2024 Apr; 23():100389. PubMed ID: 38523864
[TBL] [Abstract][Full Text] [Related]
5. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Bergman H; Henschke N; Hungerford D; Pitan F; Ndwandwe D; Cunliffe N; Soares-Weiser K
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD008521. PubMed ID: 34788488
[TBL] [Abstract][Full Text] [Related]
6. Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness.
Owusu R; Mvundura M; Nonvignon J; Armah G; Bawa J; Antwi-Agyei KO; Amponsa-Achiano K; Dadzie F; Bonsu G; Clark A; Pecenka C; Debellut F
PLOS Glob Public Health; 2023; 3(8):e0001328. PubMed ID: 37556413
[TBL] [Abstract][Full Text] [Related]
7. Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
Debellut F; Jaber S; Bouzya Y; Sabbah J; Barham M; Abu-Awwad F; Hjaija D; Ramlawi A; Pecenka C; Clark A; Mvundura M
PLoS One; 2020; 15(2):e0228506. PubMed ID: 32023295
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of rotavirus vaccination in Mozambique.
Lourenço Guimarães E; Chissaque A; Pecenka C; Clark A; Vaz B; Banze A; Canana N; Romão C; do Rosário Oliveira Martins M; de Deus N; Debellut F
Vaccine; 2022 Aug; 40(36):5338-5346. PubMed ID: 35933279
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
Villanueva-Uy MET; Lam HY; Aldaba JG; Uy TMZ; Valverde HA; Silva MWT; Mooney J; Clark A; Pecenka C
Vaccine; 2021 Nov; 39(48):7091-7100. PubMed ID: 34753614
[TBL] [Abstract][Full Text] [Related]
10. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
[TBL] [Abstract][Full Text] [Related]
11. Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines.
Debellut F; Tang K; Clark A; Pecenka C; Assao B; Guindo O; Grais RF; Isanaka S
BMJ Open; 2022 Oct; 12(10):e061673. PubMed ID: 36198460
[TBL] [Abstract][Full Text] [Related]
12. Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study.
Debellut F; Pecenka C; Hausdorff WP; Clark A
Hum Vaccin Immunother; 2022 Dec; 18(1):2040329. PubMed ID: 35240926
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal conjugate vaccination in The Gambia: health impact, cost effectiveness and budget implications.
Pecenka C; Usuf E; Hossain I; Sambou S; Vodicka E; Atherly D; Mackenzie G
BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34916274
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
